These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 21882104)

  • 61. Neonatal clinical pharmacology.
    Allegaert K; van de Velde M; van den Anker J
    Paediatr Anaesth; 2014 Jan; 24(1):30-8. PubMed ID: 23617305
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group.
    Brouwer KL; Aleksunes LM; Brandys B; Giacoia GP; Knipp G; Lukacova V; Meibohm B; Nigam SK; Rieder M; de Wildt SN;
    Clin Pharmacol Ther; 2015 Sep; 98(3):266-87. PubMed ID: 26088472
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neonatal Therapeutics: Considerations for Dosing.
    Zimmerman KO; Benjamin DK; Becker ML
    Am J Perinatol; 2019 Jul; 36(S 02):S18-S21. PubMed ID: 31238353
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Ontogeny of Phase I Metabolism of Drugs.
    Allegaert K; van den Anker J
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S33-S41. PubMed ID: 31502685
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Drug metabolizing enzymes in the perinatal and neonatal period: differences in the expression and activity.
    Cuzzolin L
    Curr Drug Metab; 2013 Feb; 14(2):167-73. PubMed ID: 22935062
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Determinants of drug metabolism in early neonatal life.
    Allegaert K; van den Anker JN; Naulaers G; de Hoon J
    Curr Clin Pharmacol; 2007 Jan; 2(1):23-9. PubMed ID: 18690852
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical pharmacokinetics in infants and children. A reappraisal.
    Kearns GL; Reed MD
    Clin Pharmacokinet; 1989; 17 Suppl 1():29-67. PubMed ID: 2692939
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children.
    de Wildt SN
    Expert Opin Drug Metab Toxicol; 2011 Aug; 7(8):935-48. PubMed ID: 21548840
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Developmental and pediatric pharmacogenomics.
    Leeder JS
    Pharmacogenomics; 2003 May; 4(3):331-41. PubMed ID: 12718723
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Developmental pharmacology: neonates are not just small adults..
    Allegaert K; Verbesselt R; Naulaers G; van den Anker JN; Rayyan M; Debeer A; de Hoon J
    Acta Clin Belg; 2008; 63(1):16-24. PubMed ID: 18386761
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Developmental Pharmacokinetics in Neonates: Maturational Changes and Beyond.
    Allegaert K; Mian P; van den Anker JN
    Curr Pharm Des; 2017; 23(38):5769-5778. PubMed ID: 28950819
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Commentary: A Myriad Aberrations on Information of Ontogeny of Drug Metabolizing Enzymes in the Pediatric Population: An Obstacle for Personalizing Drug Therapy in the Pediatric Population.
    Uppugunduri CR; Ansari M
    Drug Metab Lett; 2016; 10(2):72-4. PubMed ID: 26908134
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Industry Perspective on Using MIDD for Pediatric Studies Requiring Integration of Ontogeny.
    Corriol-Rohou S; Cheung SYA
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S112-S119. PubMed ID: 31502694
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pediatric Renal Ontogeny and Applications in Drug Development.
    Zhang Y; Mehta N; Muhari-Stark E; Burckart GJ; van den Anker J; Wang J
    J Clin Pharmacol; 2019 Sep; 59 Suppl 1():S9-S20. PubMed ID: 31502684
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Disposition and interaction of biotherapeutics in pediatric populations.
    Yanni S
    Curr Drug Metab; 2012 Sep; 13(7):882-900. PubMed ID: 22475271
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Helping trainees to become good pediatric anesthetists.
    Brown TC
    Paediatr Anaesth; 2013 Aug; 23(8):751-3. PubMed ID: 23682988
    [No Abstract]   [Full Text] [Related]  

  • 77. Metabolomics in the developing human being.
    Syggelou A; Iacovidou N; Atzori L; Xanthos T; Fanos V
    Pediatr Clin North Am; 2012 Oct; 59(5):1039-58. PubMed ID: 23036243
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Pharmacokinetic Considerations in Designing Pediatric Studies of Proteins, Antibodies, and Plasma-Derived Products.
    Mahmood I
    Am J Ther; 2016; 23(4):e1043-56. PubMed ID: 27386959
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Pharmacokinetics in the newborn.
    Alcorn J; McNamara PJ
    Adv Drug Deliv Rev; 2003 Apr; 55(5):667-86. PubMed ID: 12706549
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pediatric Age Groups and Approach to Studies.
    Job KM; Gamalo M; Ward RM
    Ther Innov Regul Sci; 2019 Sep; 53(5):584-589. PubMed ID: 31311309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.